Top Markets
Coin of the day
QuantRx Biomedical Corporation QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB
Rank in Stocks #40578
QuantRx Biomedical Corporation is engaged in the creation and marketing of its... QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
Share Price
$0.0005
Last synced: 2025-04-08
Market Cap
$118.05K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade QuantRx Biomedical Corporation (QTXB)

Category

EPS for QuantRx Biomedical Corporation (QTXB)
EPS as of 2026 TTM: 0
According to QuantRx Biomedical Corporation latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for QuantRx Biomedical Corporation from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors